Phase 2 study of neoadjuvant enzalutamide and paclitaxel for luminal androgen receptor-enriched TNBC: Trial results and insights into "ARness"
新辅助恩扎卢胺和紫杉醇治疗管腔型雄激素受体富集型三阴性乳腺癌的 II 期研究:试验结果及对“ARness”的见解
期刊:Cell Reports Medicine
影响因子:10.6
doi:10.1016/j.xcrm.2024.101595
Lim, Bora; Seth, Sahil; Yam, Clinton; Huo, Lei; Fujii, Takeo; Lee, Jangsoon; Bassett, Roland; Nasser, Sara; Ravenberg, Lisa; White, Jason; Clayborn, Alyson; Guerra, Gil; Litton, Jennifer K; Damodaran, Senthil; Layman, Rachel; Valero, Vicente; Tripathy, Debasish; Lewis, Michael; Dobrolecki, Lacey E; Lei, Jonathan; Candelaria, Rosalind; Arun, Banu; Rauch, Gaiane; Zhao, Li; Zhang, Jianhua; Ding, Qingqing; Symmans, W Fraser; Chang, Jeffrey T; Thompson, Alastair M; Moulder, Stacy L; Ueno, Naoto T